# PIQRAY

NDC: 0078-0701
Generic name: alpelisib
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190524

FDA application: NDA212526

## Active ingredients

- ALPELISIB: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0701"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0701
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b20b4e18-7a4b-4500-a08f-06c6dab0ee5b